Malignant Neoplasm of Prostate: Clinical Trials

8 trials for Malignant Neoplasm of Prostate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 unknown, 2 withdrawn. 4 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Withdrawn 2, Completed 1, Unknown 1
Phase 22Recruiting 2
Early Phase 11Unknown 1
Phase 11Recruiting 1
Phase 31Completed 1

Follow Malignant Neoplasm of Prostate: new trials by email Literature Review of Malignant Neoplasm of Prostate trials Research Report on Malignant Neoplasm of Prostate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Lu-PSMA-617, 5-fraction Stereotactic Body Radiation Therapy (SBRT) - Malignant Neoplasm of Prostate, Locally Advanced Prostate Cancer
Phase 1 / Phase 2RecruitingAngela Y. Jia, MD PhD452025-05-132026-05-26
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Androgen deprivation therapy (ADT), Androgen receptor signaling inhibitor (ARSI), Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT) - Prostate Cancer, Malignant Neoplasm of Prostate
Phase 2RecruitingCase Comprehensive Cancer Center2002024-07-012026-09-15
68Ga-AAZTA-093 PET/CT: First-in-human Study
68Ga-AAZTA-093, 68Ga-PSMA-11//68Ga-PSMA-617 - Malignant Neoplasm of Prostate
Early Phase 1UnknownFirst Affiliated Hospital of Fujian Medical University302024-04-012024-05-31
Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer
Exercise therapy - Malignant Neoplasm of Prostate
Not applicableCompletedCase Comprehensive Cancer Center212023-12-112026-09-17
Single-Port Versus Multi-Port Robotic Radical Prostatectomy
Da Vinci ® Xi system - MP Robotic Radical Prostatectomy, Da Vinci ® SP system - SP Robotic Radical Prostatectomy - Malignant Neoplasm of Prostate
Not applicableWithdrawnCase Comprehensive Cancer Center2022-09-012025-03-10
Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease
[F-18] NaF PET/CT, [F-18] fluciclovine PET/CT - Malignant Neoplasm of Prostate
Not applicableWithdrawnCase Comprehensive Cancer Center2021-03-252022-04-01
Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial
Capsules containing either dietary fiber or placebo - Malignant Neoplasm, Malignant Neoplasm of Rectum
Phase 3CompletedSahlgrenska University Hospital3542020-09-022025-09-08
Hypofractionated Radiation Therapy in Prostate Cancer
Intensity modulated radiation therapy, Volumetric modulated arc therapy, Image guided radiation therapy - Malignant Neoplasm of Prostate, Local Disease
Not applicableUnknownThomas Zilli1702012-09-012020-05-19

Narrower conditions

Prostatic Neoplasms (8)  ·  Anus Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Flatulence (1)  ·  Motor Activity (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Genital Diseases (8)  ·  Genital Diseases, Male (8)  ·  Genital Neoplasms, Male (8)  ·  Male Urogenital Diseases (8)  ·  Neoplasms by Site (8)  ·  Prostatic Diseases (8)  ·  Urogenital Diseases (8)  ·  Urogenital Neoplasms (8)  ·  Neoplasms (7)  ·  Adnexal Diseases (1)  ·  Anus Diseases (1)  ·  Behavior (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)

Interventions

Androgen Antagonists (1)  ·  Exercise Therapy (1)  ·  Pluvicto (1)  ·  Radiotherapy (1)  ·  Radiotherapy, Image-Guided (1)  ·  Radiotherapy, Intensity-Modulated (1)

Sponsors

Case Comprehensive Cancer Center (4)  ·  Angela Y. Jia, MD PhD (1)  ·  First Affiliated Hospital of Fujian Medical University (1)  ·  Sahlgrenska University Hospital (1)  ·  Thomas Zilli (1)

Countries

United States (5)  ·  Belgium (1)  ·  China (1)  ·  Finland (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Angela Y Jia, MD, PhD (2)  ·  Daniel E Spratt, MD (2)  ·  Angela Jia, MD, PhD (1)  ·  Cecilia Bull, PhD (1)  ·  Gunnar N Steineck, MD, PhD (1)  ·  Jihad Kaouk, MD (1)  ·  Maria Hedelin, PhD (1)  ·  Robert Jones, MD (1)  ·  Thomas Zilli, Dr (1)

Results publications

PMID 34950688, PMID 42838582

NIH funding

2018 (1), U01CA257638 (1)